Nuclear Medicine and Molecular Imaging Technology: University of Toronto Joint Program
Nuclear Medicine and Molecular Imaging Technology: University of Toronto Joint Program:
at a glance
Bachelor of Science in Medical Radiation Sciences from the University of Toronto & Advanced Diploma in Health Sciences from The Michener Institute of Education at UHN
8 semesters over 3 years
February 1, 2019
As a Nuclear Medicine Technologist you will become part of an interdisciplinary diagnostic imaging team. You will be employed in a variety of clinical environments including; community or teaching hospitals, private clinics, research institutes, and public health institutions.
Future career opportunities as a Nuclear Medicine and Molecular Imaging Technologist include (but are not limited to) research activities, advanced roles such as Positron Emission Tomography (PET), Computed Tomography (CT), management, education, sales/marketing. You will also be in a position to seek further training and certification in magnetic resonance imaging (MRI), ultrasound (US), and Imaging Informatics, as well as pursuing higher education opportunities at a Masters level.
Learn more about the exciting joint Michener / University of Toronto Nuclear Medicine and Molecular Imaging (NMMI) Program and how to become a NMMI Technologist by navigating the information below.
Why Nuclear Medicine and Molecular Imaging Technology at The Michener Institute/University of Toronto?
A comprehensive redesign of the Nuclear Medicine and Molecular Imaging Technology curriculum is now complete and the result is a program that encompasses the changing practice and technology in the field. The new program is a hybrid learning experience designed to meet the needs of different learners by allowing students to participate in both online and face-to-face components. Theory is put into practice by examining increasingly complex case studies and applying knowledge in both simulated and clinical environments. Students will work both independently and in teams to develop problem solving and clinical reasoning skills to support application to clinical practice.
Learners will also have the opportunity to select one of three subspecialty pathways: Magnetic Resonance Imaging (MRI), Imaging Informatics or Clinical Management. They are designed to provide learners with an option for additional career development post-graduation.
Graduates are eligible to write the national certification examination conducted by the Canadian Association of Medical Radiation Technologists (CAMRT). Certification qualifies graduates to work across Canada and allows them to register with the College of Medical Radiation Technologists of Ontario (CMRTO).
Graduates are also eligible to write the certification exam conducted by the Nuclear Medicine Technology Certification Board (NMTCB) in the United States, as well as other countries such as Australia and Britain.
Graduates earn a BSc in Medical Radiation Sciences from the University of Toronto and an Advanced Diploma in Nuclear Medicine and Molecular Imaging Technology from The Michener Institute, and may pursue advanced studies at Michener, or elsewhere, including:
Nuclear Medicine is an imaging method used to safely detect disease in its early stages. The practice of Nuclear Medicine, which includes positron emission tomography (PET), involves the use of radioactive tracers administered either by injection, orally, or inhalation. Special cameras, computers and radioactive tracers are used to image how disease or treatments alter organ system function.
Nuclear Medicine and Molecular Imaging involves non-invasive procedures that often eliminate the pain, trauma, and risk associated with invasive surgery that patients would otherwise undergo, to determine the location and size of tumours, or the extent of numerous diseases, in almost all of the human organ systems. It is able to non-invasively image and measure the body’s organs as they function, such as the amount of urine the kidneys produce per minute, the volume of blood ejected from the heart with each beat, and the extent of damage to the heart muscle due to a heart attack.
Molecular Imaging utilizes specialized instrumentation alone, or in combination with targeted imaging agents, to visualize biochemical events at the cellular and molecular level in order to help identify regions of pathology, and potential mechanisms of disease.
- Prepares and administers radiopharmaceuticals to patients
- Interacts closely with patients, physicians and other members of the health care team to obtain the best diagnostic information possible
- Acquires and analyses diagnostic images using the latest in gamma camera, PET and hybrid technologies
- Nuclear Medicine and Molecular Imaging Technologists work closely with doctors, patients and other members of the health care team. Ranging from cardiology to psychiatry, nuclear medicine images and treatments are used by a wide array of medical specialties
- Nuclear Medicine and Molecular Imaging Technology can detect disease in its very early state, leading to a more positive outcome for many patients.
- Nuclear Medicine and Molecular Imaging Technology can save patients the pain and trauma associated with investigative surgery. The images that nuclear medicine scans produce can determine the location and size of tumours or diseases without surgery
- The disciplines of Nuclear Medicine and Molecular Imaging attract responsible individuals who are people oriented, have a strong desire to help others and are attracted to working with high tech equipment and computer technology
The Nuclear Medicine and Molecular Imaging Technology program is a three-year full-time (eight consecutive semesters) undergraduate Degree/Advanced Diploma. There is one intake each year in September, and courses are conducted online and on campus at both UofT (St. George) and Michener.
Applicants to the Nuclear Medicine & Molecular Imaging Technology University of Toronto Joint Program must possess specific qualifications in order to be eligible for admissions. Please visit our Admissions Requirements by Program page for details.See Admissions Requirements
The fee policy for Canadian students can be found on the Canadian Tuition Fees web page.
The fee policy for International Students can be found on the University of Toronto, Radiation Oncology – Finances web page.
When you enroll in the Nuclear Medicine and Molecular Imaging Technology program at Michener, you will study a wide range of subjects, including the complex instrumentation associated with state-of-the-art SPECT, PET, CT and hybrid scanners, preparation of radioactive tracers, image interpretation and core health sciences such as anatomy and physiology. Aside from profession specific skills and knowledge, you will also learn about the Canadian health care system, the importance of interprofessional health care delivery, and how to provide your patients optimal care; many of these courses are taught in a collaborative environment, allowing you to learn from, about, and with other health care professional students.
The Integrated Nuclear Medicine & Molecular Imaging courses are an innovative mix of online and live delivery methods, and will incorporate patient-centred case studies and live simulations to best teach you the fundamentals of the discipline. Commencing in Semester 4, the Integrated Nuclear Medicine and Molecular Imaging courses will include clinical rotations for four days per week, every fourth week at sites throughout the Greater Toronto and Hamilton Area. This will give you first-hand experience in the workplace, and help to prepare you for your full-time clinical practicums starting in Semester 7.
Subspecialty courses allow you to select one of three pathways (MRI, Imaging Informatics or Clinical Management), which will provide you with an opportunity to develop additional career options post-graduation.
- Comparative Medical Imaging
- Introduction to Patient Care in Medical Radiation Sciences
- Nuclear Medicine Physics and Radiobiology
- Integrated Nuclear Medicine & Molecular Imaging I
- Special Topics in Patient Care I: Contrast Media/Injection
- Relational Anatomy
- Integrated Nuclear Medicine & Molecular Imaging II
- Nuclear Medicine in Practice
- Health Care Systems
- Introduction to Research Methods
- Integrated C.T. Imaging Theory and Practice I
- Integrated Nuclear Medicine & Molecular Imaging III
- Subspecialty Course I
- Clinical Behavioural Sciences
- Integrated C.T. Imaging Theory and Practice II (tentative)
- Integrated Nuclear Medicine & Molecular Imaging IV
- Subspecialty Course II
- Nuclear Medicine Clinical Practicum I (12 weeks)
- Quality in Health Care
- Subspecialty Course III
- Research Methods (13 weeks)
- Nuclear Medicine Clinical Practicum II (15 weeks)
- Research Methods (13 weeks)
- Nuclear Medicine Clinical Practicum III (15 weeks)
Note: The above curriculum is subject to change. Clinical education may be scheduled as simulation experience at Michener or as placement in clinical environments with our clinical partners.
Length: 44 weeks
Start: September (Year 2)
End: April (Year 3)
In the second year of the program, you will be placed at a Greater Toronto/Hamilton Area (GTHA) affiliated clinical site for 3 weeks during Weeks 4, 8 and 12 during both of the Fall and Winter semesters to facilitate integration of your didactic learning with hands-on clinical experience. You will then be placed at any one of our affiliated clinical sites in Ontario for three full semesters starting with the second year 12 week summer semester, followed by the Fall and Winter semesters in your third year of study. During this final clinical experience, you will be placed at the same base site for three full semesters.
As clinical education is a major component of all Michener programs, our affiliated clinical sites are integral to your education. They include teaching and community hospitals, in Ontario. Working closely under the supervision of Nuclear Medicine Technologists, you will have the opportunity to integrate knowledge and skills into practice during the clinical phase of your program. Clinical placements give you hands-on experience in work environments and the opportunity to network with potential employers.
Clinical partner sites are subject to change, therefore, specific geographic regions may not be available at the time of your placement, other regions may be added. Please note that when you accept a seat in the program, you also accept to go to any of the program’s affiliated clinical sites available at the time of your placement. In addition, you agree to comply with the following mandatory requirements which must be completed prior to the start of your clinical placement:
- CPR Certification for Health Care Providers
- N95 Mask Fit Testing
- Updated Vulnerable Sector Screening (also required upon admission)
- Updated TB Test (also required upon admission)
Michener highly recommends all students be vaccinated with influenza vaccine. This vaccine may be a requirement at some clinical sites. Students who are not vaccinated will be required to wear a mask during patient interaction throughout the influenza season (December-March).
The Nuclear Medicine and Molecular Imaging Technology program is in compliance with all five accreditation requirements (2014 Requirements for accreditation – Conjoint Accreditation Services)
For University of Toronto Bursaries, contact the MRS Program at email@example.com.
"The large opportunity for technological advancement in the Nuclear Medicine field is appealing. The use of new radiopharmaceuticals and the introduction of hybrid and fusion imaging such as SPECT/CT and PET/CT allows for more learning and development of my technical skills. With this technology on campus, Michener offers an exciting hands-on educational experience."
What I enjoy most about the Nuclear Medicine program is the interactive, hands-on labs with patient models, learning how to use radiation safely and how to use the gamma cameras to image our patients. My favourite part is my clinical rotation where I am actually able to experience what it is like to be a Nuclear Medicine Technologist. I was able to inject and do real scans on real patients."